Orofacial Pain Self-management: Personality Moderation Effect
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Self-management intervention, Clinical Practice Guideline Intervention.
- Who it may be relevant to
- Registry conditions: Chronic Orofacial Pain, Temporomandibular Disorder (TMD), Temporomandibular Disorders (TMD), Temporomandibular Dysfunction (TMD). Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Orofacial Pain Self-management: Personality Moderation Effect - Randomized Clinical Trial
Overview
The objective of this clinical trial is to study the effect of self-management on pain perception in patients with chronic orofacial pain and temporomandibular disorders (TMD) comparing it with the conventional treatment proposed by the TMD clinical practice guidelines. It also evaluates its effect on function and various psychosocial variables. As a secondary objective, this work proposes to study the variability between patients, in terms of personality factors, as moderators of the effect of treatment on pain perception. Including in the proposed statistical models certain covariates such as perception and/or coping with stress, anxiety and other psychosocial variables. This is a randomized clinical trial with two intervention groups and three measurement times (T0; pre-intervention, T1; post-5 weeks and T2; post-6 months). The experimental group will be applied a protocol based on self-management, which includes: therapeutic education, cognitive-behavioral tools, therapeutic exercise of the temporomandibular region, mind-body strategies and modifications of aspects related to lifestyle. The control group will carry out an intervention program based on the Clinical Practice Guidelines for the Management of Temporomandibular Joint Disorders. Therefore, using a set of tools based on therapeutic education, cognitive-behavioral tools for bruxism and other parafunctional habits, temporomandibular region exercises and manual therapy.
Detailed description
Temporomandibular disorders (TMD) are the most common cause of chronic orofacial pain and encompass a range of syndromes affecting the masticatory muscles and temporomandibular joints (TMJ). Approximately 9-13% of the population experiences orofacial pain related to TMD. The high complexity, multifactorial nature, recurrence, and long duration of chronic pain increase the need for approaches focused on a multi-component management, based on learning strategies and coping skills, self-efficacy, and self-care. These approaches can be classified as self-management interventions, and their multifactorial nature makes them suitable for application and teaching by various health professionals. Within this multifactoriality, previous studies have shown that the patient's personality influences the occurrence and progression of chronic pain. The objective of this study is to evaluate a comprehensive self-management program in patients with chronic orofacial pain to assess its effect on pain perception and other psychosocial and functional variables, and subsequently analyze the moderation of factors related to the patient's personality on the intervention outcomes.
It is hypothesized that the self-management-based treatment is effective in reducing pain perception in the short and medium term, and that personality is a moderating factor for the intervention's effect.
The study will be conducted on 98 subjects aged 18 to 65, diagnosed with TMD and chronic orofacial pain. The intervention will last for 10 weeks with 5 sessions of application and 3 sessions of evaluation (pre-intervention; during the session time for the first intervention application session, post-5 weeks during the session time for the last intervention application session, and post-6 months; in an extra session dedicated solely to making the evaluation record). Each intervention session will be held once every two weeks. Results will be assessed using the EVA and GCPS questionnaires (pain), PCS (catastrophizing), TSK/TMD/S (kinesiophobia), FABQ (fear-avoidance), MFIQ (mandibular dysfunction), CPSS (self-efficacy), MMO (mandibular opening), Borg (perceived fatigue), BFQ (personality), CLCD (pain locus), COPE28 (stress coping), PSS (stress perception), STAI (anxiety), pressure algometry (pain threshold), intra-articular sound quantification, and treatment-seeking behavior.
All variables will be taken in triplicate at all three measurement times with the exception of the personality-related variable (BFQ). A descriptive statistical analysis of all variables in each of the intervention groups will be performed. To analyse the effect of the intervention on pain and the other secondary variables, a repeated-means ANOVA analysis will be performed between the self-management group (GSelfManagement) and the group based on the clinical practice guideline (GGuide). To examine whether variation in pain at follow-up is influenced by personality variables and/or the psychosocial variables kinesiophobia, catastrophising thoughts, fear-avoidance, type of pain control, perception of stress and anxiety, and stress coping, a moderation and mediation analysis will be performed. This analysis determines whether the effect size of a causal variable X (VAS and GCPS, MFIQ, MMO and VAS Fatigue) on outcome Y (GGuide and GSelfManagement), depends on a moderating or mediating variable W (i.e., kinesiophobia, catastrophizing, fear-avoidance, stress and anxiety perception, stress coping, personality and type of pain control). The degree of significance will be set at p\<0.05. All analyses will be performed using statistical analysis software (SPSS 24 Inc, Chicago, Illinois, USA and The PROCESS macro for SPSS).
Interventions
- Other Self-management intervention
This intervention will implement a self-management protocol. It will consist in 5 strategy levels: educational concepts and dynamics, cognitive behavioural tools and processes, therapeutic exercise of the orofacial region, guidelines and strategies for lifestyle modification and mindbody tools. Several of the above 5 strategies will be employed in each session. Education will include TMD concepts, pain neurophysiology, contextualisation of pain in terms of perceived stress, anxiety and others. - Other Clinical Practice Guideline Intervention
Following the guidelines, 5 sessions of education, cognitive behavioural tools, jaw exercises and manual therapy will be conducted. The educational sessions will teach about TMD and basic pain concepts. A single type of cognitive behavioural tool will be employed. The aim will be to decrease bruxing and parafunctional activity during wakefulness. This will be done by training the jaw relaxation position, which will then be generalised to activities of daily living with the help of some conditio
Primary outcome measures
- Visual Analogue Scale (VAS) [Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.]
- Chronic Pain Grading Scale 2.0 Spanish Version (GCPS) [Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.]
Secondary outcome measures (12)
- Demographic data [Time frame: These data will be collected pre-intervention.]
- Pain Catastrophizing Scale (PCS) [Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.]
- The Tampa Scale of Kinesiophobia for Temporomandibular Disorders Versión Español (TSK11-TMD-S) [Time frame: It will be used in pre-intervention, post-5 weeks and post-6 months analyses.]
- Fear-Avoidance Beliefs Questionnaire (FABQ) [Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.]
- The Mandibular Function Impairment Questionnaire (MFIQ) [Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.]
- Máxima apertura de la boca (MMO) [Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.]
- Intra-articular sounds [Time frame: To be used in pre-intervention, post-5 weeks and post-6 months analyses.]
- Borg Scale [Time frame: It will be collected during each of the exercise sessions to check compliance with the intensity of the exercises. The data will not be processed statistically.]
- Big Five Personality Test (BFQ) [Time frame: This tool will be used in the pre-intervention measurement.]
- Pain Locus of Control Questionnaire (CLCD) [Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.]
- Pressure Algometry [Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses]
- The SCL-90-R Symptom Inventory [Time frame: It will be used in the pre-intervention analysis.]
Eligibility criteria
Inclusion criteria
- The patient presents TMDs diagnosed according to the CD/TMD classification.
- Age between 18 and 65.
- Presence of pain in mandibular, temporal, facial, peri-auricular and/or auricular regions.
- Presence of chronic orofacial pain. Defined by the ICD-11 as orofacial pain or headache that occurs for more than two hours a day for 50% of the days of the last three months.
- Orofacial pain is related to TMDs according to the International Classification of Headaches.
- Moderate pain intensity, corresponding to a weekly average of at least 30 mm on a 100 mm VAS (validated representation of moderate pain on the VAS scale = 31-54 mm)
Exclusion criteria
- Concomitant rheumatic systemic pathologies.
- History of trauma or recent surgical intervention in the head, face, neck or chest.
- Presence of intraoral infections or odontogenic pain.
- Headache of neuropathic origin (trigeminal neuralgia, Arnold neuralgia, etc.).
- Being receiving therapy (except rescue pharmacological therapy) for this disorder or pain.
- Cognitive impairment that prevents the follow-up of an educational program (determined through the MoCA questionnaire)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Quadruple blind
- Primary purpose
- Treatment
Study locations
Spain · 1 center
- Catholic Univerity of Valencia — Valencia
Identifiers
NCT: NCT06932406 · UCV/2023-2024/072